7 GOLDA MEIR ST., NESS ZIONA, L3
Announces Pricing of Oversubscribed Underwritten Offering
Provides Update Following Unblinding of Phase 1b Study of SGT-210 in Darier Disease
Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
Annual Meeting of Shareholders Resolutions Approved
7 GOLDA MEIR ST., WEIZMANN SCIENCE PARK NESS ZIONA, 7403650, ISRAEL
Announces Health Canada Approval of EPSOLAY®
Material disclosure
Reports First Quarter 2025 Results
Annual and Transition Report of Foreign Private Issuers
Amended Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(3)
Registration Statement for Securities of Certain Foreign Private Issuers and Certain Canadian Issuers, Offered on a Continuous Basis
No filings found
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload